Literature DB >> 7859524

Surgical treatment of primary hyperparathyroidism.

K Brasso1, S Karstrup, C M Lundby, L O Kristensen, H H Holm.   

Abstract

One hundred and two patients with primary hyperparathyroidism underwent a total of 108 bilateral neck explorations with attempted identification and biopsy of all four glands. Hypercalcaemia was surgically eliminated in 97 of 102 patients (95%). Of the remaining hypercalcaemic patients one was cured by percutaneous ethanol injection and one was reoperated and cured in another hospital. Three patients with persistent hypercalcaemia refused reoperation. Transitory hypocalcaemia with a median duration of 15 days was found in 36 patients, and permanent hypocalcaemia in two patients (1.9%). Permanent paralysis of the recurrent nerve occurred in three patients (2.9%). Twenty-one patients developed other postoperative complications from which they all recovered without sequelae. No postoperative deaths occurred. Our results show that surgical treatment of primary hyperparathyroidism--including bilateral neck exploration and attempted biopsies of all parathyroid glands--is safe with a high cure rate.

Entities:  

Mesh:

Year:  1994        PMID: 7859524

Source DB:  PubMed          Journal:  Dan Med Bull        ISSN: 0907-8916


  3 in total

1.  Delayed serum calcium biochemical response to successful parathyroidectomy in primary hyperparathyroidism.

Authors:  Yousof Alabdulkarim; Edgard Nassif
Journal:  J Lab Physicians       Date:  2010-01

2.  Selective venous sampling supports localization of adenoma in primary hyperparathyroidism.

Authors:  Masaya Ikuno; Takayuki Yamada; Yasumoto Shinjo; Tsuyoshi Morimoto; Reiko Kumano; Kunihiro Yagihashi; Takuyuki Katabami; Yasuo Nakajima
Journal:  Acta Radiol Open       Date:  2018-02-28

3.  Collapsin Response Mediator Protein-2 Ameliorates Sevoflurane-Mediated Neurocyte Injury by Targeting PI3K-mTOR-S6K Pathway.

Authors:  Jiaxuan He; Jianfang Zhu
Journal:  Med Sci Monit       Date:  2018-07-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.